Sabitlenmiş Tweet
Finding clean research compounds shouldn't be this hard.
Here is a simple guide with verified sources, safety data, and clear protocols.
Check the link in my profile.
English
Enhanced Guides | Research & Biohacking
422 posts
Enhanced Guides | Research & Biohacking
@enhancedguides
Deep diving into Peptides & Research Compounds. Protocols, safety & optimization for the modern biohacker. US sources👇 https://t.co/cQJUlUnpTp
Austin, TX Katılım Ocak 2014
788 Takip Edilen2.3K Takipçiler
@BhavanChand The purposeful cycling approach is underrated. Most people either run everything constantly or nothing at all. Context-specific deployment makes more physiological sense and keeps the compounds effective when you actually need them.
English
Once you treat peptides as tools, you can deploy them exactly when you need them
Circadian rhythm destroyed from a busy phase?
Use Epitalon - 1mg/day for 10 days
Neglected skin and hair for months?
Run GHK-Cu 3-5mg daily for 30-50 days
Heavy travel and need immune support?
Add TA-1
Simple, purposeful, and way more sustainable than running multiple compounds year-round
Not a medical advice, just for educational purposes
English
3.3K views, puikus infografikas, ADA2026 duomenys — verta komentuoti.
Retatrutide at 28% leading the glucagon arm is the clearest signal that adding energy expenditure on top of appetite suppression is the winning mechanism. The amylin camp is interesting but fullness alone has a ceiling.
English
Five new obesity drugs were unveiled at the American Diabetes Association meeting this week. Not one of them is Ozempic.
Ozempic and Wegovy work on one hormone, GLP-1. The race that just opened is about the next hormone, and the drugmakers have split into two camps.
One camp adds glucagon, a hormone that burns energy. Lilly’s retatrutide took off the most weight any drug ever has in a trial. The other camp adds amylin, the fullness hormone your pancreas already makes with insulin. Novo’s amylin combo beat plain semaglutide head to head, and an amylin drug on its own hit numbers people used to need an injection of Ozempic to reach.
There’s also a pill in the race. Lilly’s oral drug beat the oral version of Ozempic, though it’s still nowhere near the injections.
Nobody’s competing on whether these drugs work anymore. Now they’re fighting over which hormone wins, and over whether you’ll swallow it instead of inject it.
#ADA2026
English
@rorynotsorry The dopamine reward pathway angle is what explains this. GLP-1 receptors are expressed in the nucleus accumbens — it's not just appetite, it's the broader reward signal being modulated. Food noise and substance appeal are running on the same system.
English
There have been a million posts about how GLP1s like Tirzepatide and Retatrutide eliminate food noise... and food noise is the most noticeable, because its the most powerful, but it eliminates all sorts of other noise as well. The appeal of alcohol, cigarettes, drugs, video games... let’s call it temptation noise... is muted as well.
English
@agingroy The comorbidity data is what changes the conversation. When the same drug moves knee pain, sleep apnea, and blood sugar simultaneously — that's not a weight loss drug anymore. That's a metabolic disease intervention.
English
Everyone’s screenshotting the 28% weight loss from Retatrutide, but look one column to the right.
Same trial, same patients: knee arthritis pain down over 70%. Sleep apnea down over 60%. About 7 in 10 with prediabetes back to normal blood sugar.
Obesity wasn’t just a weight problem. It was dragging four other diseases along with it, and on this drug, they all moved.
Michael Weintraub, MD@MWeintraubMD
A summary slide of the TRIUMPH-1 retatrutide data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor agonist. 📅 80 weeks (20 months) | 12 mg ⬇️ 28.3% average body weight reduction ⚖️ 70.3 lbs (31.9 kg) lost 📈 Participants in Extension lost up to 30% (85 lbs) on average at 104 weeks 🎯 Weight Reduction Thresholds ✅ Nearly all lost ≥5% ✅ Over 85% lost ≥15% ✅ More than 1 in 4 lost ≥35% 📏 Anthropometric Treat-to-Target 🔵 BMI <30 → 2/3 🔵 BMI <25 → 1/3 📅 At 80 weeks | 4 mg (just 1 titration step) → 19% body weight reduction 🩺 Health Outcomes 🦵 Knee OA: >70% reduction in WOMAC pain subscale 😴 OSA: >60% reduction in AHI 🩸 Prediabetes reverted to normoglycemia in >95% of participants ⬇️ TG 41.0% | LDL 19.6% | SBP 12.3 mmHg ⚠️ Safety 🤢 Most common side effects were gastrointestinal, more frequent with RETA 9 & 12 mg 📉 Reported hypotension more common with RETA in participants on antihypertensive meds 🚽 UTIs more common with RETA, occurring mostly in female participants #ADASciSessions #Obesity #Retatrutide
English
The goal was never the highest dose.
It's the lowest dose that moves the needle — with a protocol that keeps muscle, monitors markers, and doesn't create problems you'll spend months fixing.
The drug is the easy part.
English
The other one nobody talks about: ignoring resting heart rate.
Triple agonists put load on the cardiovascular system. RHR creeping up week over week and not noticing is how people end up pausing a cycle they didn't need to pause.
Track it daily. First thing in the morning.
English
Escalating too fast is the one everyone makes.
GI side effects aren't just uncomfortable — they're a signal.
Your body is telling you it hasn't adapted yet. Pushing through doesn't speed up results. It just delays them.
English
The most expensive mistake on Retatrutide isn't the wrong vendor.
It's the wrong protocol.
English
@WorldPeptide @fitcapbiohacker 500mcg twice daily lines up with what most of the community lands on. The data here reflects real usage patterns better than anything clinical.
English
@fitcapbiohacker For my shoulder I only took 500 mcg twice a day and it worked like a miracle. And if you look at dosing data out of over 2700 researchers, the majority are taking 500mcg.
English
If your measuing your bpc-157 in mcg instead of mg your wasting your time and money
English
@hubermanlab The RCT bar is reasonable for approval but it's a slow standard for compounds with this much mechanistic and anecdotal data behind them. People aren't getting impatient — they're making rational decisions with the information available.
English
Not a day goes by where a scientific or medical colleague doesn’t ask me if they should be taking BPC for their shoulder or knee, knowing full well that there are no RCTs… I don’t know what could explain this except that perhaps people are getting impatient. What do you think?
English
@Milena_Coder Zinc and magnesium are the two that actually have solid deficiency data behind them. Most people eating a standard diet are low in both — fixing that before anything else makes more sense than adding fenugreek.
English
@operationdanish The mechanism makes sense — weight loss reduces aromatization, SHBG normalizes, free testosterone rises. The question is whether that effect holds at aggressive deficits or reverses when caloric restriction gets severe enough to suppress the HPG axis.
English
Retatrutide does improve testosterone levels… studies show:
Increased total testosterone
Increased free testosterone
Improved erectile function
Improved symptoms of obesity-related hypogonadism
John Wesley Southern@Lacedmushroom
At this point? You'd be better off just telling me it it improves testosterone levels. That's all I care about.
English
@MichaelAlbertMD The receptor downregulation piece is what makes this clinically interesting. Chronic endogenous elevation desensitizes the pathway the same way chronic exogenous exposure does. Most people claiming resistance haven't had their baseline GLP-1 levels tested.
English
The patients with the most GLP-1 in their own blood respond the worst to GLP-1 drugs.
That paradox is the cleanest proof real resistance exists.
And it's almost never what people mean when they say they have it. 🧵
English
You can eat enough protein and still lose muscle.
Chronically elevated cortisol breaks down tissue for fuel regardless of what's on your plate. It's not a nutrition problem — it's a recovery problem.
Training harder makes it worse if the stress load is already too high. The signal to build muscle and the signal to survive stress are running on the same system. One wins.
Most people optimizing their diet haven't touched their cortisol.
English
@JasonXinTX Carbs aren't the enemy here — on that level of suppression getting enough total calories is the actual challenge.
Protein is locked in, that's the hard part done:)
English
@enhancedguides Oh for sure 1200 isn’t my goal. Maintenance for me is 2200 calories. 1200 is gonna wreck me. I’m pretty good at hitting my protein goal but definitely need more carbs.
English
@Stack3dNews And these looks good :)
English
Muscle Nation drops its biggest bar to date loaded with 50g of protein stack3d.com/2026/06/muscle…
English
@marekhealth The leptin and metabolic rate angle is what actually makes this work physiologically. It's not just psychology — extended deficits downregulate adaptive thermogenesis, and a planned refeed interrupts that.
English
One Cheat Meal Can Save Your Diet
A well-planned cheat meal isn't just about satisfying cravings.
It can improve adherence, provide a mental break, and make a long dieting phase more sustainable.
The key is planning it.
A strategic cheat meal is part of the plan. An unplanned binge can derail an entire week of progress.
The best diet isn't the most restrictive one.
It's the one you can stick to.
English
@foundmyfitness The dose-response curve is what's interesting here — benefits plateau after 120 minutes weekly, but combining with aerobic activity pushes the effect significantly further. Two different mechanisms working together, not competing.
English
Strength training for 90-120 minutes per week is associated with up to a 30% lower risk of death from all causes, CVD, cancer, and neurologic disease.
That seems to be the upper limit - no additional benefit was observed above 120 minutes of strength training per week.
These benefits were independent of total aerobic activity, but combining strength training with ~5-15 hours of moderate-to-vigorous-intensity aerobic activity reduced all-cause mortality risk by 45%!
Clear message here is: "do both."
English
@himshouse What's underreported in this data — the A1C reduction in diabetics is happening alongside meaningful weight loss. Usually those trade off. Here they're compounding. That's what makes the TRANSCEND-T2D-1 results worth paying attention to.
English
$LLY $NVO $HIMS
🚨 BREAKING: ELI LILLY $LLY REPORTS ADDITIONAL POSITIVE PHASE 3 DATA FOR RETATRUTIDE
In TRIUMPH-1, 12mg dose drove 28.3% weight loss at 80 wks
Also improved knee osteoarthritis pain and obstructive sleep apnea
In TRANSCEND-T2D-1, A1C fell up to 2.0%; weight down 16.8% at 40 wks
English